Recombinant Anti-Niemann Pick C1 antibody [EPR5209] - BSA and Azide free, 100ug - ab224268

Recombinant Anti-Niemann Pick C1 antibody [EPR5209] - BSA and Azide free, 100ug - ab224268

• Product name

  Anti-Niemann Pick C1 antibody [EPR5209] - BSA and Azide free
  See all Niemann Pick C1 primary antibodies

• Description

  Rabbit monoclonal [EPR5209] to Niemann Pick C1 - BSA and Azide free

• Host species

  Rabbit

• Tested applications

  Suitable for: Flow Cyt (Intra), ICC/IF, WB, IHC-Pmore details

• Species reactivity

  Reacts with: Mouse, Rat, Human

• Immunogen

  Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.

• Positive control

  • 3T3L1 cell lysate, L6 cell lysate, HepG2 cell lysate, THP1 cell lysate, 293T cell lysate, PC3 cell lysate, Rat liver lysate, Rat brain lysate, Human kidney tissue.

• General notes

  ab224268 is the carrier-free version of ab134113.

   

  Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.

  This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

  Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with <1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

   

  This product is compatible with the Maxpar^® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar^® is a trademark of Fluidigm Canada Inc.

  This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free production

  For more information see here.

  Our RabMAb^® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb^® patents.